Evidence map›Paper›PMID 30917837›Full record

ArticleHealth research policy and systems2019

The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon's multiple streams framework.

Masoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour, Nicola Luigi Bragazzi

Open access · goldAbstract read
In one paragraph

Article in Health research policy and systems, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Achilles' heel: elderly COVID-19 vaccination policy in China.Health research policy and systems · 2024
    Article
  8. Article
  9. Hepatitis B vaccination in Iran: Historical policies and programs.Journal of preventive medicine and hygiene · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Masoud BehzadifarHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Hasan Abolghasem GorjiHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran. gorjiha@yahoo.com.ORCID http://orcid.org/0000-0002-6328-1925
Aziz RezapourHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Nicola Luigi BragazziSchool of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Iran University of Medical Sciences · IRUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis C virus (HCV) infection causes a large number of deaths annually worldwide. Policies play an important role in regulating healthcare agendas and prioritising of health-related issues. Understanding these priorities is very important in health. The objective of this study was to investigate HCV-related issues and their influence on agenda-setting in Iran.

methodsA qualitative design was used. Data were collected by carrying out a review of documents and interviews. A comprehensive search was conducted to identify documents related to HCV-related policies in Iran. Semi-structured interviews were conducted with both purposive and snowball sampling of 14 interviewees related to the HCV programme in Iran, including government officials, civil society, development partnership members and academicians. Documents and interview data were analysed manually and using MAXQDA Version 10 software. Kingdon's multiple streams framework was used to guide data analysis.

resultsThe factors which influenced HCV-related agenda-setting were lack of proper information of the HCV epidemiology before the 1990s, lack of diagnostic facilities, neighbouring countries with high HCV prevalence, the stigma of HCV, high prevalence in prisoners, international evidence and high costs generated by HCV. The factors related to policy were effective treatment methods, drug production inside Iran, Iran Hepatitis Network, support outside government group elites and academicians. The factors related to political will were international influence, changes in the government and parliament support.

conclusionThe findings of this study showed that there are various national and international factors that play a role in shaping HCV-related policies. It seems that, if HCV is put into the agenda, it can be eliminated in Iran by 2030 by supporting and implementing appropriate programmes from decision- and policy-makers.

Indexed as

Decision MakingHealth PolicyHepatitis CPolicy MakingAdministrative PersonnelCosts and Cost AnalysisHumansIranPoliticsSocial StigmaSurveys and Questionnairesagenda-settinghealth policyHepatitis CIranKingdon’s multiple streams framework

Identifiers

PMID30917837
PMCPMC6438031
OpenAlexW2946812732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.